T Jilling
Overview
Explore the profile of T Jilling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qu X, Jilling T, Neerhof M, Hirsch E, Thaete L
Pregnancy Hypertens
. 2015 Jun;
2(3):206.
PMID: 26105268
Introduction: Uterine ischemia/reperfusion (I/R) in rodents is a common model for the study of fetal growth restriction (FGR). It has been observed that different strains of mice vary in their...
2.
Caplan M, Jilling T
Lipids
. 2001 Nov;
36(9):1053-7.
PMID: 11724457
Dietary polyunsaturated fatty acid (PUFA) supplementation has been shown to reduce the incidence of necrotizing enterocolitis (NEC) in a recent randomized, controlled trial. These compounds are known to modulate the...
3.
Caplan M, Russell T, Xiao Y, Amer M, Kaup S, Jilling T
Pediatr Res
. 2001 May;
49(5):647-52.
PMID: 11328947
Inasmuch as long-chain polyunsaturated fatty acids (PUFA, metabolites of the essential n-3 and n-6 fatty acids) are known to modulate inflammation, we hypothesized that supplementation of formula with these compounds...
4.
Caplan M, Jilling T
Curr Opin Pediatr
. 2001 Apr;
13(2):111-5.
PMID: 11317050
Necrotizing enterocolitis is an overwhelming gastrointestinal emergency that primarily afflicts premature infants born weighing less than 1500 g. Despite years of investigation, the etiology remains unclear, and accepted prevention and...
5.
Braunstein G, Roman R, Clancy J, Kudlow B, Taylor A, Shylonsky V, et al.
J Biol Chem
. 2000 Dec;
276(9):6621-30.
PMID: 11110786
These studies provide evidence that cystic fibrosis transmembrane conductance regulator (CFTR) potentiates and accelerates regulatory volume decrease (RVD) following hypotonic challenge by an autocrine mechanism involving ATP release and signaling....
6.
Caplan M, Jilling T
J Pediatr Gastroenterol Nutr
. 2000 Apr;
30 Suppl 2:S18-22.
PMID: 10749397
No abstract available.
7.
Jilling T, Haddad I, Cheng S, Matalon S
Am J Physiol
. 1999 Jul;
277(1):L89-96.
PMID: 10409234
Nitric oxide (. NO) has been implicated in a wide range of autocrine and paracrine signaling mechanisms. Herein, we assessed the role of exogenous. NO in the modulation of heterologous...
8.
Bebok Z, Venglarik C, Panczel Z, Jilling T, Kirk K, Sorscher E
Am J Physiol
. 1998 Aug;
275(2):C599-607.
PMID: 9688615
The DeltaF508 mutation leads to retention of cystic fibrosis transmembrane conductance regulator (CFTR) in the endoplasmic reticulum and rapid degradation by the proteasome and other proteolytic systems. In stably transfected...
9.
Jilling T, Kirk K
Int Rev Cytol
. 1997 Jan;
172:193-241.
PMID: 9102394
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic AMP-activated chloride channel that is encoded by the gene that is defective in cystic fibrosis. This ion channel resides at...
10.
Marczin N, Jilling T, Papapetropoulos A, Go C, Catravas J
Br J Pharmacol
. 1996 Jul;
118(5):1085-94.
PMID: 8818330
1. Vascular endothelial and smooth muscle cells generate nitric oxide (NO) via different nitric oxide synthase (NOS) isozymes. Activation of the endothelial constitutive NOS (ecNOS) contributes to the maintenance of...